Neoplasms

At Agaplesion Diakonieklinikum Rotenburg gGmbH, clinical research in oncology focuses on cancers such as locally advanced, unresectable, or metastatic non-small cell lung cancer and follicular lymphoma. The trials are designed to compare new treatment approaches with standard care and to improve how effectively these cancers are controlled.

  • Testing new cancer therapies for better disease control
  • Evaluating treatment effectiveness in lung cancer and lymphoma
  • Studying options for previously untreated patients with advanced malignancies

These studies reflect a strong interest in advancing tumor treatment through more effective and targeted care.

Hemic and Lymphatic Diseases

Research in hematology at the site includes studies of chronic lymphocytic leukemia and follicular lymphoma, with a particular focus on patients at higher risk of disease progression. The goal is to assess whether newer combination treatments can extend the time before the disease worsens.

  • Exploring improved therapy for high-risk CLL
  • Comparing treatment strategies in follicular lymphoma
  • Supporting better outcomes for patients with blood cancers

This work centers on finding more effective ways to manage hematologic malignancies and reduce the burden of relapse.

Nervous System Diseases

The ACH Darmkrebszentrum also contributes to research on chemotherapy-induced polyneuropathy, a nerve-related complication that can affect patients undergoing cancer treatment. The trial aims to reduce symptoms and help preserve quality of life during therapy.

  • Preventing or reducing nerve damage linked to cancer treatment
  • Improving comfort and daily functioning in patients receiving chemotherapy
  • Assessing supportive care approaches for polyneuropathy

By addressing this side effect, the site is helping to improve the overall experience of oncology care.